Literature DB >> 17438305

Prolonged activation of the baroreflex abolishes obesity-induced hypertension.

Thomas E Lohmeier1, Terry M Dwyer, Eric D Irwin, Martin A Rossing, Robert S Kieval.   

Abstract

Prolonged electrical activation of the carotid baroreflex produces sustained reductions in sympathetic activity and arterial pressure in normotensive dogs. The main goal of this study was to assess the influence of prolonged baroreflex activation on arterial pressure and neurohormonal responses in 6 dogs with obesity-induced hypertension. After control measurements, the diet was supplemented with cooked beef fat for 6 weeks, whereas sodium intake was held constant. After 4 weeks of the high-fat diet, there were increments in body weight from 25.8+/-0.7 to 38.6+/-1.0 kg, mean arterial pressure from 97+/-2 to 110+/-3 mm Hg, heart rate from 67+/-3 to 91+/-4 bpm, and plasma norepinephrine concentration from 141+/-35 to 280+/-52 pg/mL. Plasma glucose and insulin concentrations were elevated, but increases in plasma renin activity during the initial weeks of the high-fat diet were not sustained. During week 5, baroreflex activation resulted in sustained reductions in mean arterial pressure, heart rate, and plasma norepinephrine concentration; at the end of week 5, these values were 87+/-2 mm Hg, 77+/-4 bpm, and 166+/-45 pg/mL, respectively. These suppressed values returned to week 4 levels during a 7-day recovery period after baroreflex activation. There were no changes in plasma glucose or insulin concentrations, or plasma renin activity during prolonged baroreflex activation. These findings indicate that baroreflex activation can chronically suppress the sympathoexcitation associated with obesity and abolish the attendant hypertension while having no effect on hyperinsulinemia or hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17438305     DOI: 10.1161/HYPERTENSIONAHA.107.087874

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  41 in total

1.  Does our fat tell our brain what to do? A sympathetic' appraisal.

Authors:  Gregory D Fink
Journal:  J Physiol       Date:  2010-05-01       Impact factor: 5.182

2.  Baroreflex device therapy in the treatment of hypertension.

Authors:  Sarada C Uppuluri; Eugene Storozynsky; John D Bisognano
Journal:  Curr Hypertens Rep       Date:  2009-02       Impact factor: 5.369

3.  Chronic Interactions Between Carotid Baroreceptors and Chemoreceptors in Obesity Hypertension.

Authors:  Thomas E Lohmeier; Radu Iliescu; Ionut Tudorancea; Radu Cazan; Adam W Cates; Dimitrios Georgakopoulos; Eric D Irwin
Journal:  Hypertension       Date:  2016-05-09       Impact factor: 10.190

Review 4.  Electrical carotid sinus stimulation: chances and challenges in the management of treatment resistant arterial hypertension.

Authors:  Kristine Chobanyan-Jürgens; Jens Jordan
Journal:  Curr Hypertens Rep       Date:  2015-09       Impact factor: 5.369

Review 5.  Carotid Baroreceptor Stimulation in Resistant Hypertension and Heart Failure.

Authors:  Gino Seravalle; Guido Grassi
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-03-27

6.  CrossTalk opposing view: Which technique for controlling resistant hypertension? Carotid sinus stimulation.

Authors:  Jens Jordan
Journal:  J Physiol       Date:  2014-09-15       Impact factor: 5.182

7.  Soluble Prorenin Receptor Increases Blood Pressure in High Fat-Fed Male Mice.

Authors:  Eva Gatineau; Ming C Gong; Frédérique Yiannikouris
Journal:  Hypertension       Date:  2019-08-05       Impact factor: 10.190

8.  Mechanisms of blood pressure reduction by prolonged activation of the baroreflex.

Authors:  Radu Iliescu; Thomas E Lohmeier
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2009

Review 9.  The role of the sympathetic nervous system in obesity-related hypertension.

Authors:  Alexandre A da Silva; Jussara do Carmo; John Dubinion; John E Hall
Journal:  Curr Hypertens Rep       Date:  2009-06       Impact factor: 5.369

10.  Prolonged activation of the baroreflex decreases arterial pressure even during chronic adrenergic blockade.

Authors:  Thomas E Lohmeier; Drew A Hildebrandt; Terry M Dwyer; Radu Iliescu; Eric D Irwin; Adam W Cates; Martin A Rossing
Journal:  Hypertension       Date:  2009-03-09       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.